Field Trip Health
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FTRP and buy or sell other stocks, ETFs, and their options commission-free!About FTRP
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable antidepressant for patients suffering from postpartum depression and other mental health conditions.
CEOGregory T. Mayes, III
CEOGregory T. Mayes, III
Employees—
Employees—
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2020
Founded2020
Employees—
Employees—
FTRP Key Statistics
Market cap13.12M
Market cap13.12M
Price-Earnings ratio-0.35
Price-Earnings ratio-0.35
Dividend yield—
Dividend yield—
Average volume30.83K
Average volume30.83K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$22.00
52 Week high$22.00
52 Week low$0.6303
52 Week low$0.6303
People also own
Based on the portfolios of people who own FTRP. This list is generated using Robinhood data, and it’s not a recommendation.